GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Current Deferred Revenue

Stella Diagnostics (Stella Diagnostics) Current Deferred Revenue : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Stella Diagnostics's current deferred revenue for the quarter that ended in Sep. 2023 was $0.00 Mil.

Stella Diagnostics Current Deferred Revenue Historical Data

The historical data trend for Stella Diagnostics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Current Deferred Revenue Chart

Stella Diagnostics Annual Data
Trend
Current Deferred Revenue

Stella Diagnostics Quarterly Data
Sep22 Sep23
Current Deferred Revenue - -

Stella Diagnostics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus